Specific antiplatelet autoantibodies in patients with antiphospholipid antibodies and thromocytopenia

F. Fabris, A. Steffan, I. Cordiano, P. Borzini, G. Luzzatto, M. L. Randi, A. Girolami

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

By means of immunoblotting and monoclonal antibody immobilization of platelet antigens (MAIPA) we have studied the specificity of antiplatelet antibodies in patients with antiphospholipid antibodies and thrombocytopenia defined as presence of anticardiolipin IgG and a platelet count below 100 x 109/l. The study group consisted of 10 patients with systemic lupus erythematosus (SLE), 8 patients with primary anti-phospholipid syndrome (PAPS) and 16 patients with idiopathic thrombocytopenic purpura (ITP). The comparison group was formed by 17 patients with classical chronic ITP without anticardiolipin IgG. We identified the 80-100, 130-150 and 150-170 KD surface proteins that comigrate with GPIIIa, GPIIb and GPIb and a 50-70 KD cytoplasm band by immunoblot. In patients with classical chronic ITP, the prevalence of the antiplatelet antibodies against GPIIIa was 53% on immunoblot assay and 47% on MAIPA. In ITP patients who had also anti-phospholipid antibodies in serum, the percentage of reactivity to GPIIIa declined to 37% on immunoblot and 21% on MAIPA but it was not statistically different from the percentage observed in patients. with classical ITP. Autoantibodies to platelet surface glycoproteins were almost absent in SLE and PAPS patients, who showed a significant prevalence (78%) of IgG reactivity to the 50-70 KD internal platelet protein which was frequently encountered also in patients with ITP and aPL (56%). Our study provides additional evidence that platelet antigens in patients with phospholipid-associated secondary immune thrombocytopenia are different from those of primary ITP, and that surface glycoproteins were not involved.

Original languageEnglish
Pages (from-to)232-236
Number of pages5
JournalEuropean Journal of Haematology
Volume53
Issue number4
Publication statusPublished - 1994

Fingerprint

Antiphospholipid Antibodies
Autoantibodies
Idiopathic Thrombocytopenic Purpura
Integrin beta3
Blood Platelets
Antiphospholipid Syndrome
Immunoglobulin G
Membrane Glycoproteins
Monoclonal Antibodies
Systemic Lupus Erythematosus
Phospholipids
Platelet Membrane Glycoproteins
Antibody Specificity
Platelet Count
Immunoblotting
Thrombocytopenia
Anti-Idiotypic Antibodies
Membrane Proteins
Cytoplasm

Keywords

  • Antiphospholipid antibodies
  • Antiplatelet antibodies
  • Immune thrombocytopenia
  • Immunoblot
  • MAIPA
  • SLE

ASJC Scopus subject areas

  • Hematology

Cite this

Fabris, F., Steffan, A., Cordiano, I., Borzini, P., Luzzatto, G., Randi, M. L., & Girolami, A. (1994). Specific antiplatelet autoantibodies in patients with antiphospholipid antibodies and thromocytopenia. European Journal of Haematology, 53(4), 232-236.

Specific antiplatelet autoantibodies in patients with antiphospholipid antibodies and thromocytopenia. / Fabris, F.; Steffan, A.; Cordiano, I.; Borzini, P.; Luzzatto, G.; Randi, M. L.; Girolami, A.

In: European Journal of Haematology, Vol. 53, No. 4, 1994, p. 232-236.

Research output: Contribution to journalArticle

Fabris, F, Steffan, A, Cordiano, I, Borzini, P, Luzzatto, G, Randi, ML & Girolami, A 1994, 'Specific antiplatelet autoantibodies in patients with antiphospholipid antibodies and thromocytopenia', European Journal of Haematology, vol. 53, no. 4, pp. 232-236.
Fabris, F. ; Steffan, A. ; Cordiano, I. ; Borzini, P. ; Luzzatto, G. ; Randi, M. L. ; Girolami, A. / Specific antiplatelet autoantibodies in patients with antiphospholipid antibodies and thromocytopenia. In: European Journal of Haematology. 1994 ; Vol. 53, No. 4. pp. 232-236.
@article{5022eb5cc55b456396002a72d8532b6e,
title = "Specific antiplatelet autoantibodies in patients with antiphospholipid antibodies and thromocytopenia",
abstract = "By means of immunoblotting and monoclonal antibody immobilization of platelet antigens (MAIPA) we have studied the specificity of antiplatelet antibodies in patients with antiphospholipid antibodies and thrombocytopenia defined as presence of anticardiolipin IgG and a platelet count below 100 x 109/l. The study group consisted of 10 patients with systemic lupus erythematosus (SLE), 8 patients with primary anti-phospholipid syndrome (PAPS) and 16 patients with idiopathic thrombocytopenic purpura (ITP). The comparison group was formed by 17 patients with classical chronic ITP without anticardiolipin IgG. We identified the 80-100, 130-150 and 150-170 KD surface proteins that comigrate with GPIIIa, GPIIb and GPIb and a 50-70 KD cytoplasm band by immunoblot. In patients with classical chronic ITP, the prevalence of the antiplatelet antibodies against GPIIIa was 53{\%} on immunoblot assay and 47{\%} on MAIPA. In ITP patients who had also anti-phospholipid antibodies in serum, the percentage of reactivity to GPIIIa declined to 37{\%} on immunoblot and 21{\%} on MAIPA but it was not statistically different from the percentage observed in patients. with classical ITP. Autoantibodies to platelet surface glycoproteins were almost absent in SLE and PAPS patients, who showed a significant prevalence (78{\%}) of IgG reactivity to the 50-70 KD internal platelet protein which was frequently encountered also in patients with ITP and aPL (56{\%}). Our study provides additional evidence that platelet antigens in patients with phospholipid-associated secondary immune thrombocytopenia are different from those of primary ITP, and that surface glycoproteins were not involved.",
keywords = "Antiphospholipid antibodies, Antiplatelet antibodies, Immune thrombocytopenia, Immunoblot, MAIPA, SLE",
author = "F. Fabris and A. Steffan and I. Cordiano and P. Borzini and G. Luzzatto and Randi, {M. L.} and A. Girolami",
year = "1994",
language = "English",
volume = "53",
pages = "232--236",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "4",

}

TY - JOUR

T1 - Specific antiplatelet autoantibodies in patients with antiphospholipid antibodies and thromocytopenia

AU - Fabris, F.

AU - Steffan, A.

AU - Cordiano, I.

AU - Borzini, P.

AU - Luzzatto, G.

AU - Randi, M. L.

AU - Girolami, A.

PY - 1994

Y1 - 1994

N2 - By means of immunoblotting and monoclonal antibody immobilization of platelet antigens (MAIPA) we have studied the specificity of antiplatelet antibodies in patients with antiphospholipid antibodies and thrombocytopenia defined as presence of anticardiolipin IgG and a platelet count below 100 x 109/l. The study group consisted of 10 patients with systemic lupus erythematosus (SLE), 8 patients with primary anti-phospholipid syndrome (PAPS) and 16 patients with idiopathic thrombocytopenic purpura (ITP). The comparison group was formed by 17 patients with classical chronic ITP without anticardiolipin IgG. We identified the 80-100, 130-150 and 150-170 KD surface proteins that comigrate with GPIIIa, GPIIb and GPIb and a 50-70 KD cytoplasm band by immunoblot. In patients with classical chronic ITP, the prevalence of the antiplatelet antibodies against GPIIIa was 53% on immunoblot assay and 47% on MAIPA. In ITP patients who had also anti-phospholipid antibodies in serum, the percentage of reactivity to GPIIIa declined to 37% on immunoblot and 21% on MAIPA but it was not statistically different from the percentage observed in patients. with classical ITP. Autoantibodies to platelet surface glycoproteins were almost absent in SLE and PAPS patients, who showed a significant prevalence (78%) of IgG reactivity to the 50-70 KD internal platelet protein which was frequently encountered also in patients with ITP and aPL (56%). Our study provides additional evidence that platelet antigens in patients with phospholipid-associated secondary immune thrombocytopenia are different from those of primary ITP, and that surface glycoproteins were not involved.

AB - By means of immunoblotting and monoclonal antibody immobilization of platelet antigens (MAIPA) we have studied the specificity of antiplatelet antibodies in patients with antiphospholipid antibodies and thrombocytopenia defined as presence of anticardiolipin IgG and a platelet count below 100 x 109/l. The study group consisted of 10 patients with systemic lupus erythematosus (SLE), 8 patients with primary anti-phospholipid syndrome (PAPS) and 16 patients with idiopathic thrombocytopenic purpura (ITP). The comparison group was formed by 17 patients with classical chronic ITP without anticardiolipin IgG. We identified the 80-100, 130-150 and 150-170 KD surface proteins that comigrate with GPIIIa, GPIIb and GPIb and a 50-70 KD cytoplasm band by immunoblot. In patients with classical chronic ITP, the prevalence of the antiplatelet antibodies against GPIIIa was 53% on immunoblot assay and 47% on MAIPA. In ITP patients who had also anti-phospholipid antibodies in serum, the percentage of reactivity to GPIIIa declined to 37% on immunoblot and 21% on MAIPA but it was not statistically different from the percentage observed in patients. with classical ITP. Autoantibodies to platelet surface glycoproteins were almost absent in SLE and PAPS patients, who showed a significant prevalence (78%) of IgG reactivity to the 50-70 KD internal platelet protein which was frequently encountered also in patients with ITP and aPL (56%). Our study provides additional evidence that platelet antigens in patients with phospholipid-associated secondary immune thrombocytopenia are different from those of primary ITP, and that surface glycoproteins were not involved.

KW - Antiphospholipid antibodies

KW - Antiplatelet antibodies

KW - Immune thrombocytopenia

KW - Immunoblot

KW - MAIPA

KW - SLE

UR - http://www.scopus.com/inward/record.url?scp=0028007137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028007137&partnerID=8YFLogxK

M3 - Article

VL - 53

SP - 232

EP - 236

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 4

ER -